by Clinical Neuropsychologist | Friday, January 24, 2025 | Dementia
Abstract INTRODUCTION Alzheimer’s disease (AD) patients with higher educational attainment (EA) often exhibit better cognitive function. However, the relationship among EA status, AD pathology, structural brain reserve, and cognitive decline requires further...
by Clinical Neuropsychologist | Friday, January 24, 2025 | Dementia
Abstract INTRODUCTION Lewy body dementia (LBD) shares genetic risk factors with Alzheimer’s disease (AD), including apolipoprotein E (APOE), but is distinguishable at the genome-wide level. Polygenic risk scores (PRS) may therefore improve diagnostic...
by Clinical Neuropsychologist | Thursday, January 23, 2025 | Dementia
Abstract INTRODUCTION Hearing impairment is associated with dementia. We aimed to clarify the association between hearing impairment and future cognitive test performance measured by the Montreal Cognitive Assessment Scale (MoCA), adjusted for confounders, avoiding...
by Clinical Neuropsychologist | Wednesday, January 22, 2025 | Dementia
Abstract INTRODUCTION We investigated the efficacy of a multidomain intervention (MI) via face-to-face and video communication platforms using a tablet personal computer application in patients with mild cognitive impairment (MCI). METHODS Three hundred participants...
by Clinical Neuropsychologist | Friday, January 17, 2025 | Dementia
Abstract INTRODUCTION Greater white matter hyperintensities (WMHs) on magnetic resonance imaging (MRI) are seen with transactive response DNA-binding protein 43 (TDP-43) pathology in frontotemporal lobar degeneration (FTLD-TDP). WMH associations with TDP-43 pathology...
by Clinical Neuropsychologist | Friday, January 17, 2025 | Dementia
Abstract INTRODUCTION Medicare’s Annual Wellness Visit (AWV) is a logical opportunity for early detection of cognitive impairment, but recent data for uptake and cognitive assessments during it are lacking. METHODS We surveyed Medicare beneficiaries of a...
